Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Hadassah's Fertility Expert Caters to Hopeful Potential Parents with New Clinic

Despite advances in fertility, many live with the pain of unfilled dreams of parenthood. Last week, Hadassah Medical Organization's fertility expert Prof. Ariel Revel met a large crowd of potential parents in Tel Aviv at an open meeting where he and other physicians from Hadassah along with colleagues from the Czech Republic revealed how a successful program has been able to overcome one of the common barriers in fertility: the need for egg donation.

Israel's Knesset has passed a law legalizing egg donation, but in practical terms, the supply of donor eggs in Israel is so small most Israelis cannot find a donor.

Prof. Revel has created a program where each potential parent or couple receives personalized care, including emotional support and the most advanced technology. Hadassah works together with a well-regulated Czech Republic clinic which has an abundant supply of donor eggs. The process can be coordinated with Jerusalem's Puah Institute to respect stringent Jewish religious requirements for patients who desire.

The experienced and advanced Hadassah team handles all medical and logistics issues, while providing guidance and support to the couple.

To make the process easier for those who live in Israel's populous coastal region, Prof. Revel and his staff have opened a Hadassah clinic in Tel Aviv.

Said one woman who attended the Tel Aviv open-house, "Frankly, I came to the evening with the feeling that I was joining a group of losers. But Dr. Revel made me feel that there were new possibilities and that I would receive a helping hand in undergoing a new approach to a part of my life that has been full of pain. I'm going to give it a try with Hadassah."

The OB/GYN floor of the Charlotte R. Bloomberg Mother & Child Center at Hadassah University Medical Center in Ein Kerem combines comfort and intimacy with state-of-the- art technology.

DONATE

Join

Advocate

Lead

LEARN MORE

View all of our Impact Areas


Date: 2/6/2014

FDA Grants Approval for US Clinical Trials of Hadassah-Developed Technology to Treat Fatty Liver Disease

Hadassah Physicians Receive Prestigious Grants and Awards

New Research at Hadassah: Computational Tools Unravel the Mystery of Transient Amnesia

From Life-Threatening Brain Bleed to Birth of a Daughter

Cookbook Author, Rabbi Marks, Spends Last Days at Hadassah's Hospice

Hadassah’s Revolutionary Tipat Halav Clinics of 1920s Featured in Jerusalem Old City Museum

Victims of Terror Share Their Stories of Anguish and Appreciation with Hadassah President

Hadassah’s Advanced Gene Sequencing Changes the Life of a Family from Uzbekistan

IDF Medic Heroically Battles Terrorist, Both Treated at Hadassah

Orthopedic Trauma Turns Tragedy into Innovation at Hadassah

On the Cutting-Edge of Melanoma Treatment: Hadassah’s Protocols and Research

Saving a Newborn from a Life Without Sight

Terrorist and Victim Sent to Hadassah's Hospitals After Third Attack in Two Weeks

Three Sent to Hadassah After Second Jerusalem Terror Attack of the Week

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

“We Don’t Say ‘No’,” Hadassah Neurosurgeon Explains in Operating on 82-Year-Old Patient

Cutting-Edge Medicine and Research; a Role Model for Peace: A Briefing from the Hospital's Director General

4 Ways Hadassah Hospital is Preparing for Ebola—Just in Case

Hailing from 17 Countries: the 39th Graduation Class of Hadassah’s International Master of Public Health Program

At Hadassah, Four Recover, Two Tragically Perish After Light Rail Attack



More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America